2022年伊拉克强化综合免疫服务以恢复常规疫苗接种覆盖率并将COVID-19疫苗送达人群
伊拉克COVID-19疫情期间常规免疫覆盖率降至6年低点,政府实施综合免疫服务强化(3IS)策略,在2022年2月至11月通过1321个初级卫生保健中心的延伸接种活动提供常规免疫和COVID-19疫苗。共接种4,189,859剂疫苗,其中常规免疫疫苗3,231,985剂,大幅降低零剂次儿童并提升多种疫苗覆盖率至102.2%、94.5%、91.8%和96.3%。
要点
- 3IS共开展72,495次延伸接种活动,接种4,189,859剂疫苗,占同期全国接种剂次的五分之一以上。
- 常规免疫疫苗3,231,985剂(77.1%),使2022年五联疫苗基础免疫、五联疫苗第三剂、麻疹第一剂和MMR1覆盖率分别增加18%、25%、21%和31%。
- COVID-19疫苗957,874剂(22.9%),对全国覆盖率略有提升。
核心结论
- 伊拉克的3IS策略大幅提升了常规免疫覆盖率,基本消除了疫情期间出生儿童的零剂次状态,并对COVID-19和成人疫苗接种有少量改善。
研究设计与样本
- 政府实施的全国性综合免疫服务强化(3IS)项目,覆盖1321个初级卫生保健中心,每个中心每月开展6次延伸接种活动,时间为2022年2月至11月;比较2019-2022年常规免疫行政数据和3IS期间报告数据以评估影响。
主要发现
- 3IS期间共开展72,495次延伸接种活动,接种4,189,859剂疫苗,占伊拉克这10个月接种的19,106,849剂疫苗的五分之一以上。
- COVID-19疫苗957,874剂(22.9%),对全国覆盖率略有提升。
- 常规免疫疫苗3,231,985剂(77.1%),大幅减少零剂次儿童,使2022年五联疫苗基础免疫、五联疫苗第三剂、麻疹第一剂和MMR1覆盖率分别增加18%、25%、21%和31%。
- 2022年2月至11月全国五联疫苗基础免疫、五联疫苗第三剂、麻疹第一剂和MMR1覆盖率分别达到102.2%、94.5%、91.8%和96.3%。
- 3IS活动还向符合条件者接种了133,528剂破伤风类毒素、16,353剂成人乙肝疫苗和315,032剂维生素A。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: COVID-19 seriously impacted routine immunization (RI) in Iraq. Coverage declined to a 6-year low in 2021, and COVID-19 vaccination uptake was slow. In response, government implemented intensification of integrated immunization services (3IS), a nationwide approach comprising regular outreach sessions of COVID-19 vaccination and RI for children who had either missed doses or never commenced scheduled vaccination (zero-dose children). We describe the 3IS and its impact on vaccination coverage in Iraq. METHODS: 3IS comprised new outreach sessions for urban and rural communities where administrative data suggested there were gaps in coverage. Groups of six personnel from each of 1,321 primary healthcare centres implemented six outreach sessions per month during February-November 2022. Community engagement was an integral component. We compared RI administrative data (2019-2022) and data reported during 3IS activities to assess its impact. RESULTS: In total 4,189,859 vaccine doses were administered during 72,495 3IS outreach sessions, over one-fifth of 19,106,849 vaccine doses administered in Iraq over these 10 months. Among them, 957,874 (22.9 %) were COVID-19 vaccines, adding slightly to national coverage, and 3,231,985 (77.1 %) were RI vaccines, dramatically reducing zero-dose children, adding 18 %, 25 %, 21 %, and 31 % to 2022 penta1, penta3, measles first-dose and MMR1 vaccine coverage, and contributing to national coverage of 102.2 %, 94.5 %, 91.8 % and 96.3 % for these vaccines during February-November, respectively. Moreover, 3IS sessions delivered 133,528 doses of tetanus toxoid, 16,353 doses of adult HepB vaccine, and 315,032 vitamin A doses to eligible individuals. CONCLUSION: In the context of global encouragement to integrate vaccination services, Iraq's 3IS approach enabled dramatic improvements in RI coverage, virtual elimination of zero-dose status among children born during the pandemic, and small improvements in COVID-19 and adult vaccination. Our findings provide lessons for future integrated primary care towards universal health coverage in Iraq, and for other countries yet to undertake integration.
引用
- Jabbar F, Kadhim KA, Alhilfi RA, et al. Intensification of integrated immunization services to recover routine vaccination coverage and bring COVID-19 vaccine to the population of Iraq in 2022. Vaccine. 2024. PMID: 38418341. doi:10.1016/j.vaccine.2024.02.038
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。